Clinton deal lowers HIV drug cost in poor nations
New York, August 07: Agreements between former President Bill Clinton’s foundation and two drug companies will lower prices on medications for patients with drug-resistant HIV in the developing world.
One agreement, with Mylan lowers the annual price of four antiretroviral drugs that are used as a second line of treatment when patients develop a resistance to the first drugs they are treated with.
The other agreement, with Pfizer reduces the cost of a medication that can be used in conjunction with the drugs in patients who have tuberculosis.